PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 472
- Registration Number
- NCT00716820
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 432
- Registration Number
- NCT00717093
- Locations
- 🇸🇪
Pfizer Investigational Site, Umea, Sweden
Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2009-04-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 11
- Registration Number
- NCT00716521
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder
- Conditions
- Anxiety Disorders
- Interventions
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2008-10-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 169
- Registration Number
- NCT00715039
- Locations
- 🇺🇸
Pfizer Investigational Site, Cincinnati, Ohio, United States
Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus
- First Posted Date
- 2008-07-14
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT00714116
- Locations
- 🇺🇸
Arthritis & Rheumatology Care Center, South Miami, Florida, United States
🇺🇸MRA Clinical Research, South Miami, Florida, United States
🇺🇸Miami Research Associates, South Miami, Florida, United States
Registry For Patients Treated With BeneFix In Usual Care Setting In Germany
- First Posted Date
- 2008-07-14
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 80
- Registration Number
- NCT00714415
- Locations
- 🇦🇹
Allgemeines Krankenhaus Linz, Kinderklinik, Linz, Austria
🇩🇪Werlhof-Institut für Haemostaseologie GmbH, Hannover, Niedersachsen, Germany
🇩🇪Klinikum der Martin-Luther-Universitaet Halle-Wittenberg, Halle, Germany
Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2018-10-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 31
- Registration Number
- NCT00712348
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
🇬🇧Royal Free Hospital, London, United Kingdom
🇬🇧Lysosomal Disorders Service, Addenbrookes Hospital NHS Trust, Cambridge, United Kingdom
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer
- Conditions
- Advanced Solid TumorsNon Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2008-11-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 49
- Registration Number
- NCT00712504
- Locations
- 🇺🇸
Pfizer Investigational Site, Madison, Wisconsin, United States
Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2015-07-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 926
- Registration Number
- NCT00708708
- Locations
- 🇩🇪
Westfaelische Wilhelms-Universitaet Muenster, Zentr. f. Derm, Muenster, NRW, Germany
Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
- Conditions
- Pneumonia, Bacterial
- Interventions
- Drug: imipenem/cilastatin
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 108
- Registration Number
- NCT00707239
- Locations
- 🇨🇳
Pfizer Investigational Site, Taipei, Taiwan